Pyxis Oncology, Inc. Common Stock Shares Outstanding

Quick Answer

Pyxis Oncology, Inc. reported Common Stock Shares Outstanding of 62.69 million shares for the year ending 2025.

  • Pyxis Oncology, Inc. showed an increase of +4.5% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Pyxis Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Pyxis Oncology, Inc.'s Common Stock Shares Outstanding has grown by 4,762.2%.
  • Historical annual values: Fiscal year 2025: 62.69 million shares | Fiscal year 2024: 59.97 million shares | Fiscal year 2023: 44.75 million shares | Fiscal year 2022: 34.96 million shares | Fiscal year 2021: 32.22 million shares | Fiscal year 2020: 1.29 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: